StreetInsider.com News Articles

Form 8-K Precipio, Inc. For: Aug 14

Fri, 14 Aug 2026 17:31:00 -0400

si-local-file:///var/storage/secattach/20260814/26932946.html

Form 8-K Precipio, Inc. For: Aug 14

Fri, 14 Aug 2026 17:31:00 -0400

si-local-file:///var/storage/secattach/20260814/26932946.html

Form 10-Q Precipio, Inc. For: Jun 30

Fri, 14 Aug 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260814/26929981.html

Form 10-Q Precipio, Inc. For: Jun 30

Fri, 14 Aug 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260814/26929981.html

Precipio Announces Q2-2026 Financial Results

Fri, 14 Aug 2026 16:00:00 -0400

NEW HAVEN, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the second quarter that ended June 30, 2026.

Below are some of the key financial performance metrics for the Company. For additional results please see the Company’s Form 10-Q which was filed today.

Revenue – $7.0M vs. $6.7M in Q1-2026, and up 22% YoY from $5.7M in Q2-2025. This comprised of $6.1M in pathology revenue (up from $6.0M in Q1) and $0.9M

Precipio Announces Q2-2026 Financial Results

Fri, 14 Aug 2026 16:00:00 -0400

NEW HAVEN, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the second quarter that ended June 30, 2026.

Below are some of the key financial performance metrics for the Company. For additional results please see the Company’s Form 10-Q which was filed today.

Revenue – $7.0M vs. $6.7M in Q1-2026, and up 22% YoY from $5.7M in Q2-2025. This comprised of $6.1M in pathology revenue (up from $6.0M in Q1) and $0.9M

Precipio Announces Q2-2026 Financial Results

Fri, 14 Aug 2026 16:00:00 -0400

NEW HAVEN, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the second quarter that ended June 30, 2026.

Below are some of the key financial performance metrics for the Company. For additional results please see the Company’s Form 10-Q which was filed today.

Revenue – $7.0M vs. $6.7M in Q1-2026, and up 22% YoY from $5.7M in Q2-2025. This comprised of $6.1M in pathology revenue (up from $6.0M in Q1) and $0.9M

Precipio Announces Q2-2026 Financial Results

Fri, 14 Aug 2026 16:00:00 -0400

NEW HAVEN, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the second quarter that ended June 30, 2026.

Below are some of the key financial performance metrics for the Company. For additional results please see the Company’s Form 10-Q which was filed today.

Revenue – $7.0M vs. $6.7M in Q1-2026, and up 22% YoY from $5.7M in Q2-2025. This comprised of $6.1M in pathology revenue (up from $6.0M in Q1) and $0.9M

Form 8-K Precipio, Inc. For: Jul 31

Fri, 31 Jul 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260731/26851411.html

Form 8-K Precipio, Inc. For: Jul 31

Fri, 31 Jul 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260731/26851411.html

Precipio Announces Q2-2026 Shareholder Update Call

Fri, 31 Jul 2026 16:00:00 -0400

NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at 5:00 PM ET. The call will include remarks on the company’s current core businesses, as well as a moderated live Q&A session at the end of the Company remarks.

“We are excited to share our upcoming results for Q2. The team continues to make solid progress in adding customers, expanding our pipeline, and growing the business, which will

Precipio Announces Q2-2026 Shareholder Update Call

Fri, 31 Jul 2026 16:00:00 -0400

“We are excited to share our upcoming results for Q2. The team continues to make solid progress in adding customers, expanding our pipeline, and growing the business, which will

Precipio Announces Q2-2026 Shareholder Update Call

Fri, 31 Jul 2026 16:00:00 -0400

“We are excited to share our upcoming results for Q2. The team continues to make solid progress in adding customers, expanding our pipeline, and growing the business, which will

Precipio Announces Q2-2026 Shareholder Update Call

Fri, 31 Jul 2026 16:00:00 -0400

“We are excited to share our upcoming results for Q2. The team continues to make solid progress in adding customers, expanding our pipeline, and growing the business, which will

Form 4 Precipio, Inc. For: Jul 15 Filed by: Valauri Christina Rizopoulos

Thu, 16 Jul 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260716/26780105.html

Form 4 Precipio, Inc. For: Jul 15 Filed by: Valauri Christina Rizopoulos

Thu, 16 Jul 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260716/26780105.html

Form 4 Precipio, Inc. For: Jul 15 Filed by: Cossman Jeffrey

Thu, 16 Jul 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260716/26780093.html

Form 4 Precipio, Inc. For: Jul 15 Filed by: Cossman Jeffrey

Thu, 16 Jul 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260716/26780093.html

Form 4 Precipio, Inc. For: Jul 15 Filed by: Cohen David Seth

Thu, 16 Jul 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260716/26780058.html

Form 4 Precipio, Inc. For: Jul 15 Filed by: Cohen David Seth

Thu, 16 Jul 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260716/26780058.html

Form 8-K Precipio, Inc. For: Jun 15

Mon, 15 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260615/26647166.html

Form 8-K Precipio, Inc. For: Jun 15

Mon, 15 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260615/26647166.html

Precipio seeks shareholder votes to meet quorum for annual meeting

Fri, 12 Jun 2026 13:00:37 -0400

Precipio Inc. (NASDAQ: PRPO) announced it needs additional shareholder votes to meet the required quorum for its annual shareholders meeting scheduled for June 15, 2026, at 10 a.m. Eastern Time.

The cancer diagnostics company reported that approximately 42% of shares have been voted as of the press release date. The company requires a minimum of 50% of shares to be voted to establish quorum for the meeting to proceed.

Shareholders must submit their voting instructions to brokers by 11:59 p.m. Eastern Time on June 14, 2026, for votes to be counted at the annual meeting. The company stated that votes are needed

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Fri, 12 Jun 2026 13:00:00 -0400

NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately. Votes must be received by 11:59 p.m., Eastern Time, on June 14, 2026, to be voted at the Annual Meeting.

In order to ensure that there is a quorum required for the shareholders’ meeting that is scheduled to take place tomorrow, June 15, 2026, at 10 a.m. Eastern Time.

At the time of this press release, approximately 42%

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Fri, 12 Jun 2026 13:00:00 -0400

In order to ensure that there is a quorum required for the shareholders’ meeting that is scheduled to take place tomorrow, June 15, 2026, at 10 a.m. Eastern Time.

At the time of this press release, approximately 42%